Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2025-12-24 @ 7:30 PM
NCT ID:
NCT00420303
Eligibility Criteria:
Inclusion criteria
* Spondylarthropathy
* Heel enthesitis refractory to standard treatment
* Between 18 and 70 years of age
* The patient global assessment of the disease activity (measured by a 100 mm VAS) must be \>40 in the last 48 hours
Exclusion criteria
* Use of \> 1 local steroid injection within 2 weeks of screening
* Prior exposure to any TNF-inhibitor, including etanercept
* Dose of NSAIDs changed within two weeks of study drug evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00420303
Study Brief:
Protocol Section:
NCT00420303